# reload+after+2024-01-23 01:45:39.449748
address1§2 Holzman Street
address2§Science Park PO Box 4081
city§Rehovot
zip§7670402
country§Israel
phone§972 8 940 6472
fax§972 8 940 6473
website§https://www.kamada.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Kamada Ltd., together with its subsidiaries, provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. It has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. Kamada Ltd. was incorporated in 1990 and is headquartered in Rehovot, Israel.
fullTimeEmployees§380
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Amir  London', 'age': 54, 'title': 'Chief Executive Officer', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 619000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Chaime  Orlev', 'age': 53, 'title': 'Chief Financial Officer', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 396000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Eran  Nir', 'age': 50, 'title': 'Chief Operating Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 371000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Boris  Gorelik', 'age': 42, 'title': 'Vice President of Business Development & Strategic Programs', 'yearBorn': 1981, 'fiscalYear': 2022, 'totalPay': 337000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Tsur', 'age': 73, 'title': 'Co-Founder & Deputy Chairman of the Board', 'yearBorn': 1950, 'fiscalYear': 2022, 'totalPay': 252000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Nir  Livneh B.A., L.L.B.', 'age': 44, 'title': 'VP, General Counsel & Corporate Secretary', 'yearBorn': 1979, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Hanni  Neheman', 'age': 53, 'title': 'Vice President of Marketing & Sales', 'yearBorn': 1970, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Liron  Reshef', 'age': 52, 'title': 'Vice President of Human Resources', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jon R. Knight', 'title': 'Vice President of US Commercial Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Shavit  Beladev', 'title': 'Vice President of Kamada Plasma', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.214
priceToSalesTrailing12Months§2.3033464
currency§USD
dateShortInterest§1702598400
forwardEps§0.28
pegRatio§8.57
exchange§NMS
quoteType§EQUITY
shortName§Kamada Ltd.
longName§Kamada Ltd.
firstTradeDateEpochUtc§1370007000
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a88fd904-380d-3754-b686-3fbaf4e080d7
gmtOffSetMilliseconds§-18000000
targetHighPrice§13.0
targetLowPrice§11.0
targetMeanPrice§12.0
targetMedianPrice§12.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§2.129
earningsGrowth§5.0
grossMargins§0.37201
ebitdaMargins§0.15047
trailingPegRatio§None
